LIVZON PHARMA Publishes 8 Sep 2026 Circular and First EGM Notice; Highlights Shift to E-Communication

Bulletin Express
Sep 08

On 8 September 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released two key corporate documents on both its corporate website (www.livzon.com.cn) and Hong Kong Stock Exchange’s HKEXnews platform:

• Circular dated 8 September 2026 • Notice and Proxy Form for the 2026 First Extraordinary General Meeting (EGM)

The company emphasizes digital access, recommending shareholders consult the online versions to expedite information flow and reduce printing costs. Shareholders who previously elected to receive hard copies will find the printed package enclosed with the notification.

Action options for registered shareholders: 1. Continue with electronic delivery—ensure a valid email address is on file to receive future publication alerts and actionable communications. 2. Switch to printed copies—complete and return the enclosed request form to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid label or email 1513-ecom@vistra.com. Printed materials will be provided free of charge.

Deadlines and contacts: • The current instruction on preferred communication format remains valid until 31 December 2026 unless revised by written notice. • Shareholder enquiries can be directed to Tricor’s hotline at +852 2980 1333 (09:00–18:00, Monday–Friday, excluding public holidays).

The notification underscores shareholders’ responsibility to maintain an active email address; absent a functional address, the company will default to mailing physical notices until digital details are updated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10